|
SRP54 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.13429999954096E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.591950E-02 |
| Normal-vs-Stage2 |
5.363800E-04 |
| Normal-vs-Stage3 |
1.99049998705902E-10 |
| Normal-vs-Stage4 |
3.70130000000302E-05 |
| Stage1-vs-Stage2 |
1.892000E-01 |
| Stage1-vs-Stage3 |
8.034800E-04 |
| Stage1-vs-Stage4 |
3.397800E-02 |
| Stage2-vs-Stage3 |
1.155440E-01 |
| Stage2-vs-Stage4 |
4.054200E-01 |
| Stage3-vs-Stage4 |
5.784800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.34789999994833E-06 |
| Normal-vs-AfricanAmerican |
3.75870000000056E-05 |
| Normal-vs-Asian |
5.555600E-02 |
| Caucasian-vs-AfricanAmerican |
5.279000E-01 |
| Caucasian-vs-Asian |
9.578200E-01 |
| AfricanAmerican-vs-Asian |
7.202400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.93260000008944E-07 |
| Normal-vs-Female |
7.196500E-04 |
| Male-vs-Female |
4.889800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.73381999999389E-05 |
| Normal-vs-Age(41-60Yrs) |
6.204800E-03 |
| Normal-vs-Age(61-80Yrs) |
4.42170000614084E-09 |
| Normal-vs-Age(81-100Yrs) |
1.054200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.196020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.688600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.333000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.238000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.168600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.031200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.413800E-01 |
| Normal-vs-Grade 2 |
1.240120E-04 |
| Normal-vs-Grade 3 |
3.417200E-04 |
| Normal-vs-Grade 4 |
6.94080000029906E-07 |
| Grade 1-vs-Grade 2 |
8.198400E-02 |
| Grade 1-vs-Grade 3 |
6.962000E-03 |
| Grade 1-vs-Grade 4 |
2.648600E-04 |
| Grade 2-vs-Grade 3 |
2.385800E-01 |
| Grade 2-vs-Grade 4 |
5.016800E-03 |
| Grade 3-vs-Grade 4 |
1.587350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.148400E-01 |
| Normal-vs-ccB subtype |
5.37569988523501E-13 |
| ccA subtype-vs-ccB subtype |
1.59221000000098E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.0226000004634E-07 |
| Normal-vs-N1 |
2.00150000018162E-07 |
| N0-vs-N1 |
6.330000E-02 |
|
|
